FLAVALTA Drug Patent Profile
When do Flavalta patents expire, and when can generic versions of Flavalta launch?
Flavalta is a drug marketed by Deproco and is included in one NDA.
The generic ingredient in FLAVALTA is epinephrine bitartrate; lidocaine hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; lidocaine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLAVALTA?
- What are the global sales for FLAVALTA?
- What is Average Wholesale Price for FLAVALTA?
Summary for FLAVALTA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in FLAVALTA? | FLAVALTA excipients list |
| DailyMed Link: | FLAVALTA at DailyMed |
Pharmacology for FLAVALTA
| Drug Class | Amide Local Anesthetic Antiarrhythmic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for FLAVALTA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deproco | FLAVALTA | epinephrine bitartrate; lidocaine hydrochloride | SOLUTION;INJECTION | 216564-001 | Mar 19, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
